Shionogi & Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SGIOY research report →
About the company
Shionogi & Co. , Ltd. operates as a Japanese pharmaceutical enterprise, dedicated to the discovery, creation, manufacturing, and commercialization of a diverse array of medicines, diagnostic reagents, and medical equipment within Japan.
- CEO
- Isao Teshirogi
- IPO
- 2015
- Employees
- 4,955
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $14.70B
- P/E
- 11.90
- P/S
- 4.89
- P/B
- 1.45
- EV/EBITDA
- 9.25
- Div Yield
- 2.47%
- Gross Margin
- 82.38%
- Op Margin
- 32.06%
- Net Margin
- 41.06%
- ROE
- 13.65%
- ROIC
- 5.72%
- Revenue
- $529.81B · 20.89%
- Net Income
- $217.53B · 27.63%
- EPS
- $127.83 · 27.60%
- Op Income
- $171.11B
- FCF YoY
- 18.38%
- 52W High
- $12.00
- 52W Low
- $7.65
- 50D MA
- $9.21
- 200D MA
- $9.45
- Beta
- 0.04
- Avg Volume
- 177.38K
Get TickerSpark's AI analysis on SGIOY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SGIOY coverage
Recent articles, reports, and earnings notes.
No research on SGIOY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SGIOY report →Similar companies
Peers in the same neighborhood.